SCHEMBL4856209

SCHEMBL4856209

CN(C)CCOc1ccccc1/C=C/C(=O)c1ccc(Cl)cc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.52
LMNA P02545 2/20 0.52
ATM Q13315 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
PLA2G1B P04054 1/20 0.47
ATG4B Q9Y4P1 1/20 0.47
AR P10275 3/20 0.47
CXCL12 P48061 1/20 0.47
NPC1 O15118 3/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
HPGD P15428 1/20 0.46
CYP2C19 P33261 1/20 0.46
RECQL P46063 1/20 0.46
GPR55 Q9Y2T6 1/20 0.46
KDM4E B2RXH2 3/20 0.46
GAA P10253 2/20 0.46
MAPK1 P28482 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4846123 1.00 MAPT (0.52) MAPTLMNAATMSMN1; SMN2PLA2G1B
SCHEMBL4849180 0.94 MAPT (0.51) MAPTLMNAATMSMN1; SMN2PLA2G1B
SCHEMBL4855102 0.94 MAPT (0.51) MAPTLMNAATMSMN1; SMN2PLA2G1B
SCHEMBL4846128 0.88 PTPN5 (0.54) MAPTLMNAATMSMN1; SMN2NPC1
SCHEMBL4849185 0.83 PTPN5 (0.53) MAPTLMNAATMSMN1; SMN2NPC1
SCHEMBL4846138 0.81 KDM4E (0.46) MAPTCXCL12NPC1CYP1A2CYP3A4
SCHEMBL4852869 0.81 KDM4E (0.46) MAPTCXCL12NPC1CYP1A2CYP3A4
SCHEMBL4846784 0.81 BCHE (0.58) CXCL12ABCG2
SCHEMBL4857406 0.81 BCHE (0.58) CXCL12ABCG2
SCHEMBL4852227 0.81 KDM4E (0.56) MAPTLMNASMN1; SMN2CXCL12NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed